Screener
532 of 532 companies · Download this screen (CSV)Columns
| From the filings Tickdelta | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | Ticker | Company | Revenue, 5 yrs | Sector▼ | Industry | Sales (ttm) | Sales growth | Net m. | New | New risks | Acct. items | Insider buys |
| 251 | BIIB | Biogen | -26% | Health care | Biotechnology | $10.3B | +2.2% | 3.4% | 2 new | 8 | ||
| 252 | BMY | Bristol Myers Squibb | +13% | Health care | Pharmaceuticals | $50.0B | -0.2% | 18.5% | 2 new | 7 | ||
| 253 | BSX | Boston Scientific | +103% | Health care | Medical Instruments | $21.1B | +19.9% | 16.6% | 2 new | 3 | 1 | 1 |
| 254 | CAH | Cardinal Health | +56% | Health care | Drug Wholesale | $257.8B | +14.2% | 0.7% | 2 new | 17 | ||
| 255 | CI | Cigna | +71% | Health care | Health Insurance | $286.3B | +11.2% | 2.1% | 2 new | 22 | ||
| 256 | CNC | Centene Corporation | +75% | Health care | Health Insurance | $203.9B | +19.4% | 0.7% | 2 new | 6 | 1 | |
| 257 | COO | Cooper Companies | +68% | Health care | Eye Care | $4.2B | +5.1% | 13.5% | 1 new | 4 | 1 | 5 |
| 258 | COR | Cencora | +69% | Health care | Drug Wholesale | $332.8B | +9.3% | 0.8% | 3 new | 14 | ||
| 259 | CRL | Charles River Laboratories | +37% | Health care | Research Services | $4.0B | -0.9% | 1.0% | 3 new | 21 | 1 | |
| 260 | CVS | CVS Health | +50% | Health care | Pharmacies | $420.6B | +7.8% | 2.6% | 4 new | 9 | 1 | |
| 261 | DGX | Quest Diagnostics | +17% | Health care | Medical Labs | $11.8B | +11.8% | 9.5% | 3 new | 3 | ||
| 262 | DHR | Danaher Corporation | +10% | Health care | Industrial Instruments | $25.6B | +2.9% | 16.9% | 3 new | 6 | ||
| 263 | DVA | DaVita | +18% | Health care | Health Services | $14.2B | +6.5% | 6.5% | 2 new | 29 | 1 | |
| 264 | DXCM | Dexcom | +142% | Health care | Medical Instruments | $5.1B | +15.6% | 19.4% | 2 new | 18 | 2 | |
| 265 | ELV | Elevance Health | +63% | Health care | Health Insurance | $201.8B | +12.5% | 2.5% | 4 new | 9 | ||
| 266 | EW | Edwards Lifesciences | +38% | Health care | Medical Devices | $6.7B | +11.5% | 15.3% | 2 new | 11 | ||
| 267 | GEHC | GE HealthCare | +17% | Health care | Medical Imaging | $21.6B | +4.8% | 10.0% | 3 new | 9 | 2 | |
| 268 | GILD | Gilead Sciences | +19% | Health care | Biotechnology | $31.0B | +2.4% | -12.5% | 2 new | 13 | ||
| 269 | HCA | HCA Healthcare | +47% | Health care | Hospitals | $78.7B | +7.1% | 8.6% | 4 new | 16 | ||
| 270 | HSIC | Henry Schein | +30% | Health care | Medical Distribution | $13.7B | +4.0% | 3.1% | 2 new | 41 | 1 | |
| 271 | HUM | Humana | +68% | Health care | Health Insurance | $154.2B | +10.1% | 0.8% | 4 new | 3 | 1 | |
| 272 | IDXX | Idexx Laboratories | +59% | Health care | Diagnostics | $4.7B | +10.4% | 25.4% | 2 new | 2 | ||
| 273 | ILMN | Illumina, Inc. | +34% | Health care | Lab Instruments | $4.5B | -0.7% | 19.7% | 3 new | 7 | 2 | |
| 274 | INCY | Incyte | +93% | Health care | Research Services | $6.0B | +21.2% | 6.7% | 2 new | 6 | 1 | |
| 275 | IQV | IQVIA | +44% | Health care | Research Services | $17.3B | +5.9% | 8.1% | 2 new | 7 | ||
| 276 | ISRG | Intuitive Surgical | +131% | Health care | Medical Devices | $11.6B | +20.5% | 25.5% | 3 new | 17 | ||
| 277 | JNJ | Johnson & Johnson | +14% | Health care | Pharmaceuticals | $99.3B | +6.0% | 16.2% | 2 new | 6 | 1 | |
| 278 | LH | Labcorp | -0% | Health care | Medical Labs | $14.6B | +7.2% | 6.9% | 4 new | 26 | ||
| 279 | LLY | Eli Lilly | +166% | Health care | Pharmaceuticals | $86.5B | +44.7% | 31.9% | 2 new | 9 | 3 | |
| 280 | MCK | McKesson | +69% | Health care | Drug Wholesale | $418.8B | +12.4% | 1.1% | 2 new | 6 | ||
| 281 | MDT | Medtronic | +21% | Health care | Medical Devices | $37.5B | +8.4% | 13.9% | 1 new | 14 | ||
| 282 | MRK | Merck & Co. | +57% | Health care | Pharmaceuticals | $67.4B | +1.3% | 3.6% | 3 new | 12 | 2 | |
| 283 | MRNA | Moderna | +142% | Health care | Biotechnology | $2.5B | -39.9% | -110.5% | 2 new | 29 | 1 | |
| 284 | MTD | Mettler Toledo | +31% | Health care | Lab Instruments | $4.2B | +4.0% | 22.2% | 2 new | 6 | ||
| 285 | PFE | Pfizer | +50% | Health care | Pharmaceuticals | $63.6B | -1.6% | 6.3% | 3 new | 6 | ||
| 286 | PODD | Insulet Corporation | +199% | Health care | Medical Instruments | $3.2B | +30.7% | 13.4% | 2 new | 13 | 1 | 1 |
| 287 | REGN | Regeneron Pharmaceuticals | +69% | Health care | Pharmaceuticals | $16.9B | +1.0% | 28.5% | 2 new | 22 | ||
| 288 | RMD | ResMed | +77% | Health care | Medical Instruments | $5.7B | +9.9% | 27.8% | 2 new | 17 | 1 | |
| 289 | RVTY | Revvity | +7% | Health care | Lab Instruments | $2.9B | +3.7% | 8.6% | 2 new | 4 | 1 | |
| 290 | SOLV | Solventum | +2% | Health care | Medical Instruments | $8.2B | +0.9% | 1.9% | 2 new | 15 | 2 | |
| 291 | STE | Steris | +91% | Health care | Medical Devices | $6.2B | +8.7% | 13.4% | 5 new | 10 | ||
| 292 | SYK | Stryker Corporation | +75% | Health care | Medical Instruments | $26.3B | +11.2% | 13.8% | 4 new | 1 | ||
| 293 | TECH | Bio-Techne | +31% | Health care | Biotechnology | $1.2B | -0.4% | 14.0% | 3 new | 31 | ||
| 294 | TMO | Thermo Fisher Scientific | +38% | Health care | Measuring Instruments | $47.4B | +3.9% | 14.9% | 3 new | 2 | ||
| 295 | UHS | Universal Health Services | +50% | Health care | Hospitals | $18.4B | +9.7% | 8.0% | 2 new | 7 | ||
| 296 | UNH | UnitedHealth Group | +74% | Health care | Health Insurance | $449.7B | +11.8% | 3.5% | 3 new | 5 | 1 | |
| 297 | VEEV | Veeva Systems | +118% | Health care | Software | $3.5B | +16.3% | 29.3% | 1 new | 19 | ||
| 298 | VRTX | Vertex Pharmaceuticals | +93% | Health care | Pharmaceuticals | $13.0B | +8.9% | 30.7% | 3 new | 466 | 4 | |
| 299 | VTRS | Viatris | +20% | Health care | Pharmaceuticals | $14.7B | -3.0% | -4.1% | 2 new | 18 | ||
| 300 | WAT | Waters Corporation | +34% | Health care | Lab Instruments | $5.6B | +7.0% | 1.8% | 2 new | 82 | 1 | |
Growth and margins are for the last fiscal year. Columns in the blue band come from reading the filings, which is what Tickdelta adds. "New" counts filings since you last opened the company; it is kept in this browser only.